Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy : Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy

Status: Recruiting
Location: See location...
Intervention Type: Radiation
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Thanks to the intrinsic qualities of the proton beam, proton therapy will reduce adverse effects of irradiation. The Proteus®One is the latest generation of proton therapy equipment, enabling the Centre Antoine Lacassagne to expand its range of treatments by carrying out new proton therapy treatments. It has an innovative compact isocentric rotating head (Gantry) that allows the radiation beam to be directed at different angles around the patient. In some cases, two beams are used to treat tumours, and by convention, both beams are delivered during the same session. However, it is necessary to position the patient before each beam, which is time-consuming because 2 beams have to be positioned very precisely each day. The aim of this study is therefore to assess the toxicity of proton therapy delivered by a single daily beam compared with proton therapy delivered by two daily beams, which is the conventional technique.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Chordoma, chondrosarcoma of the skull base and spine, Ewing's sarcoma, and osteosarcoma meeting the criteria for treatment by proton therapy

• Tumour requiring 2 beams

• MRI less than one month old

• PS 0-2.

• Patient who has read the patient information note and signed the consent form.

• Patient with healthcare insurance cover.

• Age over 18 years.

• For women of childbearing age, negative urine pregnancy test and effective contraception in place for the duration of treatment and for six months following the end of treatment.

Locations
Other Locations
France
Centre Antoine lacassagne
RECRUITING
Nice
Contact Information
Primary
Clement DEVIC, PhD
clement.devic@nice.unicancer.fr
0492031511
Time Frame
Start Date: 2023-09-13
Estimated Completion Date: 2031-10-01
Participants
Target number of participants: 106
Treatments
Experimental: 1DB
One daily Beam treatment
Active_comparator: 2DB
Two daily beam goldstandard
Sponsors
Leads: Centre Antoine Lacassagne

This content was sourced from clinicaltrials.gov